Outcomes of allogeneic hematopoietic cell transplantation for patients with hematologic malignancies with and without pre-existing fungal infections.
Study #: IN09-01
Study Status: Published
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.
Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee J-W, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML.
Bone Marrow Transplantation. 2017, Feb 01: 52(2): 52(2):270-278. doi: 10.1038/bmt.2016.259. Epub 2016, Dec 19. PMCID:PMC5358320.
PMID: 27991895
Abstract